$KLIC
Kulicke and Soffa Industries Inc

2024 Q2 Form 10-Q Financial Statement

#000005697824000064 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $181.7M $172.1M
YoY Change 4.99%
Cost Of Revenue $96.92M $155.6M
YoY Change 8.99%
Gross Profit $84.73M $16.47M
YoY Change 0.76%
Gross Profit Margin 46.64% 9.57%
Selling, General & Admin $38.52M $39.45M
YoY Change 8.61%
% of Gross Profit 45.46% 239.51%
Research & Development $37.94M $37.70M
YoY Change 5.38%
% of Gross Profit 44.77% 228.91%
Depreciation & Amortization $3.694M $5.642M
YoY Change -25.81%
% of Gross Profit 4.36% 34.25%
Operating Expenses $76.45M $121.6M
YoY Change 6.98%
Operating Profit $8.277M -$105.2M
YoY Change -34.46%
Interest Expense $8.040M $18.00K
YoY Change 25025.0%
% of Operating Profit 97.14%
Other Income/Expense, Net
YoY Change
Pretax Income $16.32M -$96.33M
YoY Change -20.78%
Income Tax $4.053M $6.355M
% Of Pretax Income 24.84%
Net Earnings $12.26M -$102.7M
YoY Change -18.46%
Net Earnings / Revenue 6.75% -59.67%
Basic Earnings Per Share $0.22 -$1.83
Diluted Earnings Per Share $0.22 -$1.83
COMMON SHARES
Basic Shares Outstanding 55.46M shares 56.34M shares
Diluted Shares Outstanding 55.72M shares 56.15M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $601.9M $634.7M
YoY Change -18.01%
Cash & Equivalents $366.9M $359.7M
Short-Term Investments $350.7M $375.0M
Other Short-Term Assets $35.30M $40.31M
YoY Change -42.58%
Inventory $175.6M $180.5M
Prepaid Expenses
Receivables $200.3M $194.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.013B $1.050B
YoY Change -14.79%
LONG-TERM ASSETS
Property, Plant & Equipment $64.54M $65.00M
YoY Change -41.69%
Goodwill $88.93M $89.08M
YoY Change -10.07%
Intangibles $25.74M $27.14M
YoY Change -35.47%
Long-Term Investments $2.900M $2.254M
YoY Change -46.62%
Other Assets $9.156M $10.06M
YoY Change 185.59%
Total Long-Term Assets $244.1M $248.3M
YoY Change -27.16%
TOTAL ASSETS
Total Short-Term Assets $1.013B $1.050B
Total Long-Term Assets $244.1M $248.3M
Total Assets $1.257B $1.299B
YoY Change -17.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $52.15M $51.49M
YoY Change -4.93%
Accrued Expenses $44.28M $43.45M
YoY Change 21.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $166.0M $165.7M
YoY Change -15.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.83M $13.46M
YoY Change -15.25%
Total Long-Term Liabilities $13.83M $13.46M
YoY Change -15.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $166.0M $165.7M
Total Long-Term Liabilities $13.83M $13.46M
Total Liabilities $283.7M $286.5M
YoY Change -16.65%
SHAREHOLDERS EQUITY
Retained Earnings $1.241B $1.240B
YoY Change -8.04%
Common Stock $590.9M $584.6M
YoY Change 4.21%
Preferred Stock
YoY Change
Treasury Stock (at cost) $838.8M $794.2M
YoY Change 16.56%
Treasury Stock Shares
Shareholders Equity $973.5M $1.012B
YoY Change
Total Liabilities & Shareholders Equity $1.257B $1.299B
YoY Change -17.51%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $12.26M -$102.7M
YoY Change -18.46%
Depreciation, Depletion And Amortization $3.694M $5.642M
YoY Change -25.81%
Cash From Operating Activities $26.90M -$20.15M
YoY Change 1377.86%
INVESTING ACTIVITIES
Capital Expenditures $2.683M $6.571M
YoY Change -74.78%
Acquisitions
YoY Change
Other Investing Activities $39.28M $10.00M
YoY Change -128.74%
Cash From Investing Activities $36.59M $3.429M
YoY Change -124.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -55.93M -47.67M
YoY Change 235.31%
NET CHANGE
Cash From Operating Activities 26.90M -20.15M
Cash From Investing Activities 36.59M 3.429M
Cash From Financing Activities -55.93M -47.67M
Net Change In Cash 7.558M -64.39M
YoY Change -104.66%
FREE CASH FLOW
Cash From Operating Activities $26.90M -$20.15M
Capital Expenditures $2.683M $6.571M
Free Cash Flow $24.21M -$26.72M
YoY Change -374.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Interest Expense
InterestExpense
40000 usd
us-gaap Interest Expense
InterestExpense
66000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56684000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56154000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57577000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15041000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
121626000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
71463000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-105155000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
18000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
32000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20597000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6355000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5556000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-102680000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15041000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.83
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.83
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56154000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-102680000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3027000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1654000 usd
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-55000 usd
CY2023Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
9000 usd
CY2024Q1 klic Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent
ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent
-2972000 usd
CY2023Q2 klic Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent
ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent
1645000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-1189000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
737000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-28000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
578000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1161000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
159000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4133000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1804000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-106813000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16845000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1174561000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
315000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
5932000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2640000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27479000 usd
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26840000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7542000 usd
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11303000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
9293000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7683000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16976000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1161251000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
315000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
37329000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5917000 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11164000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-102680000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4133000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-106813000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1012177000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1194650000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
237000 usd
CY2022Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
45382000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6284000 usd
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10794000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14589000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17645000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32234000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1177229000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
237000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4990000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5142000 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10766000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15041000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1804000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16845000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1183697000 usd
us-gaap Net Income Loss
NetIncomeLoss
-93387000 usd
us-gaap Net Income Loss
NetIncomeLoss
29630000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14952000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12155000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
44472000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
14089000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
11900000 usd
klic Increase Decrease Due To Inventory Valuation
IncreaseDecreaseDueToInventoryValuation
65681000 usd
klic Increase Decrease Due To Inventory Valuation
IncreaseDecreaseDueToInventoryValuation
1694000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12563000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6227000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-43000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
217000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
423000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1689000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2613000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
36491000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-141637000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28644000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39055000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13406000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2107000 usd
klic Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-7784000 usd
klic Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-41286000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-21713000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-30655000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
86936000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
36881000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10997000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24515000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
235000 usd
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
1115000 usd
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
36000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
430000000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
270000000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
385000000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
145000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57112000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-186197000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
306000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
326000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
63477000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
52048000 usd
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
22013000 usd
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
20537000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85796000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-72911000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
733000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5737000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-169654000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-166435000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
529402000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
555537000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
359748000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
389102000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
8269000 usd
us-gaap Interest Paid Net
InterestPaidNet
40000 usd
us-gaap Interest Paid Net
InterestPaidNet
66000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17488000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
41930000 usd
us-gaap Basis Of Accounting
BasisOfAccounting
1. BASIS OF PRESENTATION<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“we,” “us,” “our,” or the “Company”), with appropriate elimination of intercompany balances and transactions. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim consolidated condensed financial statements are unaudited and, in management’s opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Annual Report”) filed with the Securities and Exchange Commission on November 16, 2023, which includes the Consolidated Balance Sheets as of September 30, 2023 and October 1, 2022, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders’ Equity and Cash Flows for each of the years in the three-year period ended September 30, 2023. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2024 quarters end on December 30, 2023, March 30, 2024, June 29, 2024 and September 28, 2024. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2023 quarters ended on December 31, 2022, April 1, 2023, July 1, 2023 and September 30, 2023. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designs, develops, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company’s operating results depend upon the capital and operating expenditures of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry’s demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, solutions and services, including those sold or provided by the Company. These downturns and slowdowns have in the past adversely affected the Company’s operating results. The Company believes such volatility will continue to characterize the industry and the Company’s operations in the future.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the cancellation of a project with one of its strategic customers (previously referred to as Project W), on March 11, 2024, the Company committed to a plan to cease operational activities and commence wind down activities concerning various aspects of Project W. The wind down activities are ongoing and are expected to be substantially completed by the end of fiscal year 2024. For additional information, see Note 16: Restructuring and Cancellation of Project in our Notes to the Consolidated Condensed Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory and inventory valuation, carrying value and lives of fixed assets, goodwill and intangible assets, accrual for customer credit programs, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, accrual for employee termination benefits and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of March 30, 2024. While there was no material impact from macroeconomic headwinds to our consolidated condensed financial statements as of and for the quarter ended March 30, 2024, these estimates may change, as new events occur and additional information is obtained, including factors related to these headwinds, that could materially impact our consolidated condensed financial statements in future reporting periods. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our significant accounting policies summarized in Note 1: Basis of Presentation to our Consolidated Financial Statements included in our 2023 Annual Report. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revision of Segment-Related Disclosures within the Previously Issued Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal year 2023, in response to comment letters from the staff of the Securities and Exchange Commission (the "SEC"), the Company reconsidered the guidance under ASC 280, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and determined that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements, included in our Annual Report on Form 10-K for the year ended October 1, 2022, originally filed with the SEC on November 17, 2022 (the "Original Form 10-K"). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated the materiality of the incorrect presentation of its segment-related disclosures in the notes to its consolidated financial statements and has concluded that it did not result in a material misstatement of the Company’s previously issued consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the changes to the Company’s operating and reportable segments, the Company has revised, in this Quarterly Report on Form 10-Q, the segment-related disclosures in Note 14: Segment Information, to update the prior period presentation. The effect of this revision has been reflected in all footnotes impacted by this revision.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Improvements </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, the Financial Accounting Standards Board (the "FASB") issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This ASU aligns the requirements in the FASB Accounting Standards Codification with the SEC’s regulations. The amendments in the ASU are expected to clarify or improve disclosure and presentation requirements of a variety of Codification Topics. They will also allow users to more easily compare entities subject to the SEC’s existing disclosures with those entities that were not previously subject to the requirements, and align the requirements in the Codification with the SEC’s regulations. This ASU will become effective for each amendment on the date on which the SEC removes the related disclosure from its regulations. However, if by June 30, 2027, the SEC has not removed the related disclosure from its regulations, the amendments will be removed from the Codification and not become effective for any entity. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 280): Improvements to Reportable Segment Disclosure, which aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments in the ASU enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The purpose of the amendments is to enable investors to better understand an entity's overall performance and assess potential future cash flows. This ASU will be effective for the Company's fiscal year 2025, and interim periods within the fiscal years beginning after the Company’s fiscal year 2026. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span> (Topic 740): Improvement to Income Tax Disclosures. The amendments in this update are intended to enhance the transparency and decision usefulness of income tax disclosures primarily through changes to the rate reconciliation and income taxes paid information. This ASU will be effective for the Company's fiscal year 2026. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
63046000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
74555000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
54804000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
49207000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
235647000 usd
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
409000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
89082000 usd
CY2023Q3 klic Goodwill Cumulative Impairment
GoodwillCumulativeImpairment
45000000 usd
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div>Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2024 quarters end on December 30, 2023, March 30, 2024, June 29, 2024 and September 28, 2024. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2023 quarters ended on December 31, 2022, April 1, 2023, July 1, 2023 and September 30, 2023.
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory and inventory valuation, carrying value and lives of fixed assets, goodwill and intangible assets, accrual for customer credit programs, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, accrual for employee termination benefits and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div>In light of macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of March 30, 2024. While there was no material impact from macroeconomic headwinds to our consolidated condensed financial statements as of and for the quarter ended March 30, 2024, these estimates may change, as new events occur and additional information is obtained, including factors related to these headwinds, that could materially impact our consolidated condensed financial statements in future reporting periods.
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
117797000 usd
CY2023Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
114827000 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
238589000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
55106000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
21285000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
180541000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
217304000 usd
CY2024Q1 us-gaap Land
Land
2182000 usd
CY2023Q3 us-gaap Land
Land
2182000 usd
CY2024Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23184000 usd
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23105000 usd
CY2024Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
84987000 usd
CY2023Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
82927000 usd
CY2024Q1 klic Equipment And Software Gross
EquipmentAndSoftwareGross
39709000 usd
CY2023Q3 klic Equipment And Software Gross
EquipmentAndSoftwareGross
37483000 usd
CY2024Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
100336000 usd
CY2023Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
95692000 usd
CY2024Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
11072000 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
11099000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
261470000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
252488000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
154960000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
142437000 usd
CY2024Q1 klic Accumulated Impairment Property Plant And Equipment
AccumulatedImpairmentPropertyPlantAndEquipment
41507000 usd
CY2023Q3 klic Accumulated Impairment Property Plant And Equipment
AccumulatedImpairmentPropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65003000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
110051000 usd
CY2024Q1 srt Payables To Customers
PayablesToCustomers
32399000 usd
CY2023Q3 srt Payables To Customers
PayablesToCustomers
35701000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24420000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33096000 usd
CY2024Q1 klic Accrued Liabilities For Commission And Professional Fees Current
AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent
11164000 usd
CY2023Q3 klic Accrued Liabilities For Commission And Professional Fees Current
AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent
10710000 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
4398000 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
4091000 usd
CY2024Q1 klic Accrued Leasehold Renovations
AccruedLeaseholdRenovations
7613000 usd
CY2023Q3 klic Accrued Leasehold Renovations
AccruedLeaseholdRenovations
11005000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10132000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8402000 usd
CY2024Q1 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
90126000 usd
CY2023Q3 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
103005000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
88673000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
132241000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
105102000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27139000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
130929000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
101572000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29357000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2535000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5069000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5069000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4794000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4362000 usd
CY2024Q1 klic Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
5310000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
27139000 usd
CY2024Q1 us-gaap Cash
Cash
36654000 usd
CY2024Q1 klic Cash Unrealized Gains
CashUnrealizedGains
0 usd
CY2024Q1 klic Cash Unrealized Losses
CashUnrealizedLosses
0 usd
CY2024Q1 klic Cash Estimated Fair Value
CashEstimatedFairValue
36654000 usd
CY2024Q1 klic Cashand Cash Equivalents Amortized Cost
CashandCashEquivalentsAmortizedCost
359761000 usd
CY2024Q1 klic Cashand Cash Equivalents Gross Unrealized Gain
CashandCashEquivalentsGrossUnrealizedGain
0 usd
CY2024Q1 klic Cashand Cash Equivalents Gross Unrealized Loss
CashandCashEquivalentsGrossUnrealizedLoss
13000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
359748000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
275000000 usd
CY2024Q1 klic Availableforsale Securities Shortterm Investments Gross Unrealized Gain
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain
0 usd
CY2024Q1 klic Availableforsale Securities Shortterm Investments Gross Unrealized Loss
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss
0 usd
CY2024Q1 klic Availableforsale Securities Shortterm Investments Fair Value Disclosure
AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure
275000000 usd
CY2024Q1 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments
634761000 usd
CY2024Q1 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain
0 usd
CY2024Q1 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss
13000 usd
CY2024Q1 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure
634748000 usd
CY2023Q3 us-gaap Cash
Cash
37292000 usd
CY2023Q3 klic Cash Unrealized Gains
CashUnrealizedGains
0 usd
CY2023Q3 klic Cash Unrealized Losses
CashUnrealizedLosses
0 usd
CY2023Q3 klic Cash Estimated Fair Value
CashEstimatedFairValue
37292000 usd
CY2023Q3 klic Cashand Cash Equivalents Amortized Cost
CashandCashEquivalentsAmortizedCost
529412000 usd
CY2023Q3 klic Cashand Cash Equivalents Gross Unrealized Gain
CashandCashEquivalentsGrossUnrealizedGain
0 usd
CY2023Q3 klic Cashand Cash Equivalents Gross Unrealized Loss
CashandCashEquivalentsGrossUnrealizedLoss
10000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
529402000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
230000000 usd
CY2023Q3 klic Availableforsale Securities Shortterm Investments Gross Unrealized Gain
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain
0 usd
CY2023Q3 klic Availableforsale Securities Shortterm Investments Gross Unrealized Loss
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss
0 usd
CY2023Q3 klic Availableforsale Securities Shortterm Investments Fair Value Disclosure
AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure
230000000 usd
CY2023Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments
759412000 usd
CY2023Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain
0 usd
CY2023Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss
10000 usd
CY2023Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure
759402000 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2254000 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
716000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2200000 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
100000 usd
CY2024Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
49625000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
414000 usd
CY2023Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
54590000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
723000 usd
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
P12M
klic Leases Numberof Options To Extend
LeasesNumberofOptionsToExtend
0 extend_options
CY2024Q1 us-gaap Lease Cost
LeaseCost
2558000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
2683000 usd
us-gaap Lease Cost
LeaseCost
5415000 usd
us-gaap Lease Cost
LeaseCost
5273000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
4705000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
4673000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y8M12D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.072
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4849000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9453000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7037000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5041000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4780000 usd
CY2024Q1 klic Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
22606000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
53766000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12438000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
41328000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7021000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34307000 usd
CY2017Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2018Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000 usd
CY2022Q1 klic Stock Repurchase Program Authorized Amount Additional Amount
StockRepurchaseProgramAuthorizedAmountAdditionalAmount
400000000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
800000000 usd
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2024Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
11300000 usd
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
22000000 usd
klic Relative Total Shareholder Return Average Stock Price Calculation Period
RelativeTotalShareholderReturnAverageStockPriceCalculationPeriod
P90D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
9000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
10000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
795000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
802000 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6232000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5379000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14089000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11900000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6232000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5379000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14089000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11900000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
28987000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10181000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
26317000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
223000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2893000 usd
CY2024Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
0 usd
CY2023Q2 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
0 usd
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
-10181000 usd
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
0 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
29210000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
29210000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8579000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7781000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4797000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3160000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-11229000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-9276000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-19772000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-16546000 usd
CY2024Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
9316000 usd
CY2023Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
8051000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
21641000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
19942000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6666000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6556000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6666000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6556000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-102680000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-102680000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15041000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15041000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56154000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56154000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56684000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56684000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
893000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56154000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57577000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.83
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.83
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2024Q1 klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
0
CY2023Q2 klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.83
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
416000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Net Income Loss
NetIncomeLoss
-93387000 usd
us-gaap Net Income Loss
NetIncomeLoss
-93387000 usd
us-gaap Net Income Loss
NetIncomeLoss
29630000 usd
us-gaap Net Income Loss
NetIncomeLoss
29630000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56402000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56402000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56868000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56868000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
871000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56402000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57739000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
0
klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
412000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000 shares
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6355000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5556000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8632000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9314000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.066
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.270
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.102
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2024Q1 us-gaap Revenues
Revenues
172074000 usd
CY2023Q2 us-gaap Revenues
Revenues
173021000 usd
us-gaap Revenues
Revenues
343263000 usd
us-gaap Revenues
Revenues
349254000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-105155000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
12629000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-103462000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
24451000 usd
CY2024Q1 us-gaap Revenues
Revenues
172074000 usd
CY2023Q2 us-gaap Revenues
Revenues
173021000 usd
us-gaap Revenues
Revenues
343263000 usd
us-gaap Revenues
Revenues
349254000 usd
CY2024Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
3846000 usd
CY2023Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
17383000 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
7379000 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
33034000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
5642000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
4979000 usd
us-gaap Depreciation
Depreciation
12280000 usd
us-gaap Depreciation
Depreciation
9198000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1325000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1563000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2672000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2957000 usd
klic Period Of Warranty For Manufacturing Defects
PeriodOfWarrantyForManufacturingDefects
P1Y
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10167000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
11421000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10457000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13443000 usd
CY2024Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3133000 usd
CY2023Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2882000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
6069000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4982000 usd
CY2024Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3393000 usd
CY2023Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3835000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
6619000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
7957000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
9907000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10468000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
9907000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10468000 usd
CY2024Q1 klic Inventory Purchase Obligation Future Minimum Payments Due
InventoryPurchaseObligationFutureMinimumPaymentsDue
153529000 usd
CY2024Q1 klic Inventory Purchase Obligation Future Minimum Payments Due Current
InventoryPurchaseObligationFutureMinimumPaymentsDueCurrent
45085000 usd
CY2024Q1 klic Inventory Purchase Obligation Future Minimum Payments Due In Two Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInTwoYears
108444000 usd
CY2024Q1 klic Inventory Purchase Obligation Future Minimum Payments Due In Three Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInThreeYears
0 usd
CY2024Q1 klic Inventory Purchase Obligation Future Minimum Payments Due In Four Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInFourYears
0 usd
CY2024Q1 klic Inventory Purchase Obligation Future Minimum Payments Due In Five Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInFiveYears
0 usd
CY2024Q1 klic Inventory Purchase Obligation Future Minimum Payments Due Thereafter
InventoryPurchaseObligationFutureMinimumPaymentsDueThereafter
0 usd
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
57333000 usd
CY2024Q1 klic Purchase Order Cancellation Expense
PurchaseOrderCancellationExpense
2834000 usd
CY2024Q1 us-gaap Severance Costs1
SeveranceCosts1
2940000 usd
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
44472000 usd
CY2024Q1 us-gaap Restructuring Costs
RestructuringCosts
107579000 usd
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
57300000 usd
CY2024Q1 us-gaap Severance Costs1
SeveranceCosts1
2900000 usd
CY2024Q1 klic Purchase Order Cancellation Expense
PurchaseOrderCancellationExpense
2800000 usd
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000056978-24-000064-index-headers.html Edgar Link pending
0000056978-24-000064-index.html Edgar Link pending
0000056978-24-000064.txt Edgar Link pending
0000056978-24-000064-xbrl.zip Edgar Link pending
a10qq22024ex311.htm Edgar Link pending
a10qq22024ex312.htm Edgar Link pending
a10qq22024ex321.htm Edgar Link pending
a10qq22024ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
klic-20240330.htm Edgar Link pending
klic-20240330.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
klic-20240330_cal.xml Edgar Link unprocessable
klic-20240330_def.xml Edgar Link unprocessable
klic-20240330_lab.xml Edgar Link unprocessable
klic-20240330_pre.xml Edgar Link unprocessable
klic-20240330_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending